Search results
Showing 3661 to 3675 of 8236 results
Read biographies of the members of our quality standards advisory committee.
Policies, procedures, reports and codes of practice relating to the governance of NICE.
View a complete list of all our guidance, NICE advice and quality standards currently in development
Biographies for all current members of the diagnostics advisory committee.
Advises NICE on the formulation of its guidance on the safety and efficacy of interventional procedures.
Membership details, terms of reference, future meeting dates and past meeting minutes for our 4 technology appraisal committees.
Our framework agreement allows UK NHS, health and social care organisations to buy knowledge resources that support practice, learning and development.
Check to see if you're entitled to access a range of content purchased by the NHS. If you are eligible, you can register for an OpenAthens account using our online form.
NHS OpenAthens accounts are managed by a network of administrators who can answer questions and offer support to users in England.
Bisphosphonates for treating osteoporosis Patient decision aid What is osteoporosis and how can bisphosphonates help? Everyone's bones get weaker as...
Our resource planner tool to help you plan for and implement NICE guidance.
We estimate the costs or savings (resource impact) associated with technologies and guidelines so you can plan for and implement guidance.
Our modular updates framework ensures flexibility and consistency in updating our manuals and helps prioritise important updates.
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.
This indicator covers the percentage of patients with a new diagnosis of hypertension in the preceding 1 April to 31 March who have a record of a 12-lead ECG performed in the 3 months before or after the date of entry to the hypertension register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM77